DOCU insider buying and SEC filings, explained
Docusign, Inc. · CIK 1261333
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$3.0M
Planned sales (10b5-1)
$20.2M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Nov 2, 2026 | Planned (10b5-1) | Paula Hansen (Chief Revenue Officer) sold 3,300 shares at $81.82 ($270K), marked as a 10b5-1 plan trade. Holdings down 3% to 103,258 shares. | SEC filing Filed Nov 3, 2026, 6:35 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | Paula Hansen (Chief Revenue Officer) sold 3,300 shares at about $68.81 ($227K), marked as a 10b5-1 plan trade. Holdings down 3% to 106,557 shares. | SEC filing Filed Oct 2, 2026, 7:59 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | James P Shaughnessy (Chief Legal Officer) sold 12,000 shares at about $68.80 ($826K), marked as a 10b5-1 plan trade. Holdings down 19% to 50,591 shares. | SEC filing Filed Oct 2, 2026, 7:58 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | Allan C. Thygesen (CEO and Director) sold 26,250 shares at about $69.29 ($1.8M), marked as a 10b5-1 plan trade. Holdings down 14% to 166,801 shares. | SEC filing Filed Oct 2, 2026, 7:58 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | Mary Agnes Wilderotter (Director) sold 1,000 shares at $68.80 ($69K), marked as a 10b5-1 plan trade. Holdings down 31% to 2,199 shares. | SEC filing Filed Oct 2, 2026, 7:58 PM ET |
| Sep 17, 2026 | Planned (10b5-1) | Robert Chatwani (President / COO) sold 14,676 shares at about $69.41 ($1.0M), marked as a 10b5-1 plan trade. Holdings down 16% to 75,928 shares. | SEC filing Filed Sep 21, 2026 |
| Sep 16, 2026 | Planned (10b5-1) | Mary Agnes Wilderotter (Director) sold 1,096 shares at $70.60 ($77K), marked as a 10b5-1 plan trade. Holdings down 26% to 3,199 shares. | SEC filing Filed Sep 16, 2026 |
| Sep 14, 2026 | Planned (10b5-1) | Anna Marrs (Director) sold 548 shares at $67.00 ($37K), marked as a 10b5-1 plan trade. Holdings down 4% to 13,525 shares. | SEC filing Filed Sep 15, 2026 |
| Sep 10, 2026 | Planned (10b5-1) | Teresa Briggs (Director) sold 548 shares at $64.60 ($35K), marked as a 10b5-1 plan trade. Holdings down 5% to 10,811 shares. | SEC filing Filed Sep 11, 2026 |
| Sep 10, 2026 | Sale | Peter Solvik (Director) sold 46,000 shares indirectly (by trust) at about $65.24 ($3.0M). Holdings by trust down 25% to 90,253 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 11, 2026 |
| Sep 4–8, 2026 | Planned (10b5-1) Amended filing | Blake Jeffrey Grayson (CFO) sold 45,000 shares between Sep 4 and Sep 8 at about $68.52 ($3.1M), marked as a 10b5-1 plan trade. Holdings down 36% to 81,429 shares. This amends a filing from Sep 8. | SEC filing Filed Sep 9, 2026 |
| Aug 28, 2026 | Planned (10b5-1) | James A. Beer (Director) sold 450 shares at $64.02 ($29K), marked as a 10b5-1 plan trade. Holdings down 3% to 14,586 shares. | SEC filing Filed Aug 28, 2026 |
| Aug 7, 2026 | Planned (10b5-1) | Blake Jeffrey Grayson (CFO) sold 15,000 shares at $60.00 ($900K), marked as a 10b5-1 plan trade. Holdings down 11% to 126,429 shares. | SEC filing Filed Aug 11, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Paula Hansen (Chief Revenue Officer) sold 6,000 shares at $45.54 ($273K), marked as a 10b5-1 plan trade. Holdings down 6% to 89,972 shares. | SEC filing Filed Jul 1, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Blake Jeffrey Grayson (CFO) sold 15,000 shares at about $45.55 ($683K), marked as a 10b5-1 plan trade. Holdings down 10% to 141,429 shares. | SEC filing Filed Jul 1, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Allan C. Thygesen (CEO and Director) sold 26,250 shares at about $46.02 ($1.2M), marked as a 10b5-1 plan trade. Holdings down 14% to 159,038 shares. | SEC filing Filed Jul 1, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | James P Shaughnessy (Chief Legal Officer) sold 12,000 shares at about $45.54 ($546K), marked as a 10b5-1 plan trade. Holdings down 19% to 52,815 shares. | SEC filing Filed Jul 1, 2026 |
| Jun 22, 2026 | Planned (10b5-1) | Robert Chatwani (President / COO) sold 15,902 shares at about $43.01 ($684K), marked as a 10b5-1 plan trade. Holdings down 18% to 72,805 shares. | SEC filing Filed Jun 22, 2026 |
| Jun 5, 2026 | Planned (10b5-1) | Anna Marrs (Director) sold 363 shares at $49.42 ($18K), marked as a 10b5-1 plan trade. Holdings down 3% to 12,977 shares. | SEC filing Filed Jun 5, 2026 |
| May 29, 2026 | Planned (10b5-1) | Teresa Briggs (Director) sold 365 shares at $50.04 ($18K), marked as a 10b5-1 plan trade. Holdings down 3% to 10,263 shares. | SEC filing Filed Jun 2, 2026 |
| Jun 2, 2026 | Planned (10b5-1) | James A. Beer (Director) sold 450 shares at $55.04 ($25K), marked as a 10b5-1 plan trade. Holdings down 3% to 15,036 shares. | SEC filing Filed Jun 2, 2026 |
| Jun 2, 2026 | Planned (10b5-1) | Anna Marrs (Director) sold 365 shares at $55.04 ($20K), marked as a 10b5-1 plan trade. Holdings down 3% to 12,615 shares. | SEC filing Filed Jun 2, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Paula Hansen (Chief Revenue Officer) sold 6,000 shares at about $46.84 ($281K), marked as a 10b5-1 plan trade. Holdings down 7% to 79,233 shares. | SEC filing Filed Apr 2, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Allan C. Thygesen (CEO and Director) sold 26,250 shares at about $47.78 ($1.3M), marked as a 10b5-1 plan trade. Holdings down 15% to 152,237 shares. | SEC filing Filed Apr 2, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | James P Shaughnessy (Chief Legal Officer) sold 12,000 shares at about $46.83 ($562K), marked as a 10b5-1 plan trade. Holdings down 18% to 53,631 shares. | SEC filing Filed Apr 2, 2026 |
| Mar 18, 2026 | Planned (10b5-1) | Robert Chatwani (President / COO) sold 16,696 shares at about $48.10 ($803K), marked as a 10b5-1 plan trade. Holdings down 19% to 72,458 shares. | SEC filing Filed Mar 19, 2026 |
| Mar 5, 2026 | Planned (10b5-1) | Anna Marrs (Director) sold 363 shares at $46.33 ($17K), marked as a 10b5-1 plan trade. Holdings down 3% to 12,251 shares. | SEC filing Filed Mar 5, 2026 |
| Mar 3, 2026 | Planned (10b5-1) | James A. Beer (Director) sold 450 shares at $45.02 ($20K), marked as a 10b5-1 plan trade. Holdings down 3% to 14,757 shares. | SEC filing Filed Mar 3, 2026 |
| Mar 3, 2026 | Planned (10b5-1) | Anna Marrs (Director) sold 365 shares at $45.02 ($16K), marked as a 10b5-1 plan trade. Holdings down 3% to 11,889 shares. | SEC filing Filed Mar 3, 2026 |
| Feb 27, 2026 | Planned (10b5-1) | Teresa Briggs (Director) sold 364 shares at $44.31 ($16K), marked as a 10b5-1 plan trade. Holdings down 4% to 9,170 shares. | SEC filing Filed Feb 27, 2026 |
| Jan 9, 2026 | Planned (10b5-1) | Blake Jeffrey Grayson (CFO) sold 6,500 shares at $70.00 ($455K), marked as a 10b5-1 plan trade. Holdings down 5% to 111,713 shares. | SEC filing Filed Jan 13, 2026 |
| Jan 9, 2026 | Planned (10b5-1) | Allan C. Thygesen (CEO and Director) sold 26,250 shares at about $69.60 ($1.8M), marked as a 10b5-1 plan trade. Holdings down 16% to 142,261 shares. | SEC filing Filed Jan 13, 2026 |
| Jan 2, 2026 | Planned (10b5-1) | Paula Hansen (Chief Revenue Officer) sold 6,000 shares at about $67.05 ($402K), marked as a 10b5-1 plan trade. Holdings down 8% to 68,970 shares. | SEC filing Filed Jan 6, 2026 |
| Jan 2, 2026 | Planned (10b5-1) | James P Shaughnessy (Chief Legal Officer) sold 12,000 shares at about $67.03 ($804K), marked as a 10b5-1 plan trade. Holdings down 18% to 54,550 shares. | SEC filing Filed Jan 6, 2026 |
| Dec 15–17, 2025 | Planned (10b5-1) | Robert Chatwani (President / COO) sold 15,501 shares between Dec 15, 2025 and Dec 17, 2025 at about $68.61 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 18% to 70,197 shares. | SEC filing Filed Dec 17, 2025 |
| Dec 17, 2025 | Planned (10b5-1) | Blake Jeffrey Grayson (CFO) sold 9,515 shares at about $68.33 ($650K), marked as a 10b5-1 plan trade. Holdings down 7% to 118,213 shares. | SEC filing Filed Dec 17, 2025 |
| Dec 11, 2025 | Planned (10b5-1) | Robert Chatwani (President / COO) sold 983 shares at $68.62 ($67K), marked as a 10b5-1 plan trade. Holdings down 1% to 70,179 shares. | SEC filing Filed Dec 12, 2025 |
| Dec 5, 2025 | Planned (10b5-1) | Anna Marrs (Director) sold 363 shares at $64.50 ($23K), marked as a 10b5-1 plan trade. Holdings down 3% to 11,525 shares. | SEC filing Filed Dec 5, 2025 |
| Dec 2, 2025 | Planned (10b5-1) | James A. Beer (Director) sold 450 shares at $68.54 ($31K), marked as a 10b5-1 plan trade. Holdings down 3% to 14,478 shares. | SEC filing Filed Dec 2, 2025 |
| Dec 2, 2025 | Planned (10b5-1) | Anna Marrs (Director) sold 365 shares at $68.54 ($25K), marked as a 10b5-1 plan trade. Holdings down 3% to 11,163 shares. | SEC filing Filed Dec 2, 2025 |
| Nov 28, 2025 | Planned (10b5-1) | Teresa Briggs (Director) sold 365 shares at $69.19 ($25K), marked as a 10b5-1 plan trade. Holdings down 4% to 8,805 shares. | SEC filing Filed Dec 2, 2025 |
74 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow DOCU in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.